MicrobiologybioRxiv
Tackling Recalcitrant Pseudomonas aeruginosa Infections In Critical Illness via Anti-virulence Monotherapy
V. K. SINGH, M. Almpani, D. Maura…·L. G. Rahme
This study identifies novel anti-MvfR compounds (NAMs) that reduce intestinal permeability and inflammation in Pseudomonas aeruginosa infections, offering a potential monotherapy for critical illness.
DOI 10.1038/s41467-022-32833-9